A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401

被引:0
|
作者
In-Jae Oh
Kyu-Sik Kim
Young-Chul Kim
Hee-Jung Ban
Yong-Soo Kwon
Yu-Il Kim
Sung-Chul Lim
Woong-Ki Chung
Taek-Keun Nam
Joo-Young Song
Mee-Sun Yoon
Sung-Ja Ahn
机构
[1] Chonnam National University Hwasun Hospital,Lung and Esophageal Cancer Clinic
[2] Chonnam National University,Department of Internal Medicine
[3] Chonnam National University,Department of Radiation Oncology
来源
Cancer Chemotherapy and Pharmacology | 2013年 / 72卷
关键词
Non-small cell lung cancer; Concurrent chemoradiotherapy; Paclitaxel; Docetaxel; Gemcitabine;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1247 / 1254
页数:7
相关论文
共 50 条
  • [1] A phase III concurrent chemoradiotherapy trial with cisplatin and paclitaxel or docetaxel or gemcitabine in unresectable non-small cell lung cancer: KASLC 0401
    Oh, In-Jae
    Kim, Kyu-Sik
    Kim, Young-Chul
    Ban, Hee-Jung
    Kwon, Yong-Soo
    Kim, Yu-Il
    Lim, Sung-Chul
    Chung, Woong-Ki
    Nam, Taek-Keun
    Song, Joo-Young
    Yoon, Mee-Sun
    Ahn, Sung-Ja
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2013, 72 (06) : 1247 - 1254
  • [2] Phase III trial of cisplatin/gemcitabine with or without vinorelbine or paclitaxel in advanced non-small cell lung cancer
    Comella, P
    SEMINARS IN ONCOLOGY, 2001, 28 (02) : 7 - 10
  • [3] Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
    Vokes, EE
    Crawford, J
    Bogart, J
    Socinski, MA
    Clamon, G
    Green, MR
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5045S - 5050S
  • [4] Clinical Outcome of Palliative Concurrent Chemoradiotherapy with Cisplatin/Docetaxel for Stage III Non-small Cell Lung Cancer
    Katsui, Kuniaki
    Ogata, Takeshi
    Watanabe, Kenta
    Yoshio, Kotaro
    Kuroda, Masahiro
    Hiraki, Takao
    Kiura, Katsuyuki
    Maeda, Yoshinobu
    Toyooka, Shinichi
    Kanazawa, Susumu
    ACTA MEDICA OKAYAMA, 2021, 75 (03) : 269 - 277
  • [5] Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III A/B Unresectable Non-small Cell Lung Cancer
    Movsas, Benjamin
    Langer, Corey J.
    Ross, Helen J.
    Wang, Luhua
    Jotte, Robert M.
    Feigenberg, Steve
    Xu, Feng
    Huang, Chao H.
    Monberg, Matthew J.
    Obasaju, Coleman K.
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (05) : 673 - 679
  • [6] Concurrent chemoradiotherapy with cisplatin and vinorelbine for stage III non-small cell lung cancer
    Naito, Yoichi
    Kubota, Kaoru
    Nihei, Keiji
    Fujii, Tomonori
    Yoh, Kiyotaka
    Niho, Seiji
    Goto, Koichi
    Ohmatsu, Hironobu
    Saijo, Nagahiro
    Nishiwaki, Yutaka
    JOURNAL OF THORACIC ONCOLOGY, 2008, 3 (06) : 617 - 622
  • [7] Etoposide and cisplatin versus paclitaxel and carboplatin with concurrent thoracic radiotherapy in unresectable stage III non-small cell lung cancer: a multicenter randomized phase III trial
    Liang, J.
    Bi, N.
    Wu, S.
    Chen, M.
    Lv, C.
    Zhao, L.
    Shi, A.
    Jiang, W.
    Xu, Y.
    Zhou, Z.
    Wang, W.
    Chen, D.
    Hui, Z.
    Lv, J.
    Zhang, H.
    Feng, Q.
    Xiao, Z.
    Wang, X.
    Liu, L.
    Zhang, T.
    Du, L.
    Chen, W.
    Shyr, Y.
    Yin, W.
    Li, J.
    He, J.
    Wang, L.
    ANNALS OF ONCOLOGY, 2017, 28 (04) : 777 - 783
  • [8] Docetaxel plus cisplatin concurrent chemoradiotherapy followed by the same regimen consolidation in unresectable stage III non-small-cell lung cancer - Result of a phase I Trial
    Bao Yong
    Zhuang Ting-ting
    Hu Xiao
    Wang Wei-hua
    Gao Jianming
    He Han
    Sun Zong-wen
    Wang Yan
    Paudle, Shivoji
    Chen Ming
    JOURNAL OF THORACIC ONCOLOGY, 2009, 4 (09) : S939 - S940
  • [9] Phase II trial of gemcitabine and cisplatin (GC) as neoadjuvant chemotherapy in unresectable stage III non-small cell lung cancer (NSCLC).
    Crino, L
    Mazzoni, F
    Maestri, A
    Calandri, C
    Selvaggi, G
    Scagliotti, GV
    De Marinis, F
    Gregorc, V
    Darwish, S
    Tonato, M
    ANNALS OF ONCOLOGY, 2000, 11 : 108 - 108
  • [10] Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small cell lung cancer: A phase III randomized trial
    Georgoulias, V.
    Ardavanis, A.
    Tsiafaki, X.
    Agelidou, A.
    Syrigos, K.
    Polyzos, A.
    Kakolyris, S.
    Kouroussis, Ch
    Androulakis, N.
    Chatzidaki, D.
    ANNALS OF ONCOLOGY, 2004, 15 : 169 - 169